Literature DB >> 17012337

Movement disorders in patients taking anticonvulsants.

C Zadikoff1, R P Munhoz, A N Asante, N Politzer, R Wennberg, P Carlen, A Lang.   

Abstract

BACKGROUND: A wide variety of movement disorders may occur as a consequence of the administration of antiepileptic drugs (AEDs). Although it has been suggested that the risk of parkinsonism is 10-fold higher in those taking valproate as compared with other AEDs, there have been no large, systematic trials assessing this. AIM: To establish more precisely the prevalence of and risk factors for developing parkinsonism associated with valproate use,and to assess the occurrence of movement disorders with the newer AEDs.
METHODS: Patients with epilepsy were recruited from the Toronto Western Hospital Epilepsy Clinic (University of Toronto, Toronto, Ontario, Canada). Each patient was examined by a movement disorder specialist who was blinded to the treatment status of the patient.
RESULTS: 201 patients were included. Postural tremor was the most common movement disorder (45%), followed by parkinsonism (4.5%). The odds of having parkinsonism were 5 times higher with valproate than with other AEDs. No single factor predicted the presence of parkinsonism; however, many (5/9) of the patients concurrently used other drugs or had comorbidities that could have caused or exacerbated parkinsonism. None of the newer AEDs were clearly associated with the presence of movement disorders; however, the numbers were too small to make a formal analysis.
CONCLUSION: Although the risk of parkinsonism with valproate is higher than with other AEDs, it is lower than originally reported. The cases available were not enough to accurately comment on the prevalence of movement disorders with the newer AEDs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012337      PMCID: PMC2077655          DOI: 10.1136/jnnp.2006.100222

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

1.  Valproic acid toxicity mimicking multiple system atrophy.

Authors:  H A Shill; T D Fife
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

2.  A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia.

Authors:  N Pineda-Trujillo; L G Carvajal-Carmona; O Buriticá; S Moreno; C Uribe; D Pineda; M Toro; F García; W Arias; G Bedoya; F Lopera; A Ruiz-Linares
Journal:  Neurosci Lett       Date:  2001-02-02       Impact factor: 3.046

3.  Zonisamide has beneficial effects on Parkinson's disease patients.

Authors:  M Murata; E Horiuchi; I Kanazawa
Journal:  Neurosci Res       Date:  2001-12       Impact factor: 3.304

4.  Movement disorder as a manifestation of diphenylhydantoin intoxication.

Authors:  J C Kooiker; S M Sumi
Journal:  Neurology       Date:  1974-01       Impact factor: 9.910

5.  Severe bradykinesia as a manifestation of toxicity to antiepileptic medications.

Authors:  A L Prensky; D C DeVivo; H Palkes
Journal:  J Pediatr       Date:  1971-04       Impact factor: 4.406

6.  Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics.

Authors:  D Chadwick; E H Reynolds; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

7.  Transient dystonias in three patients treated with tiagabine.

Authors:  T Wolańczyk; A Grabowska-Grzyb
Journal:  Epilepsia       Date:  2001-07       Impact factor: 5.864

Review 8.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

9.  Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate.

Authors:  K Easterford; P Clough; M Kellett; K Fallon; S Duncan
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

10.  Camptocormia, a new side effect of sodium valproate.

Authors:  S Kiuru; M Iivanainen
Journal:  Epilepsy Res       Date:  1987-07       Impact factor: 3.045

View more
  24 in total

Review 1.  Medication-Induced Tardive Dyskinesia: A Review and Update.

Authors:  Elyse M Cornett; Matthew Novitch; Alan David Kaye; Vijay Kata; Adam M Kaye
Journal:  Ochsner J       Date:  2017

Review 2.  Neurobiological perspective of 22q11.2 deletion syndrome.

Authors:  Janneke R Zinkstok; Erik Boot; Anne S Bassett; Noboru Hiroi; Nancy J Butcher; Claudia Vingerhoets; Jacob A S Vorstman; Therese A M J van Amelsvoort
Journal:  Lancet Psychiatry       Date:  2019-08-05       Impact factor: 27.083

3.  Valproate-Induced Generalized Choreoathetosis.

Authors:  Alfonso Giordano; Marianna Amboni; Alessandro Tessitore
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

4.  A Complex Hyperkinesia Induced by Valproate.

Authors:  Elisa Bruno; Paul Holmes; Michalis Koutroumanidis
Journal:  Mov Disord Clin Pract       Date:  2016-01-29

5.  Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.

Authors:  Jacob Taylor; William S Anderson; Jason Brandt; Zoltan Mari; Gregory M Pontone
Journal:  Am J Geriatr Psychiatry       Date:  2016-09-03       Impact factor: 4.105

6.  Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics.

Authors:  Susana Barbosa Ribeiro; Aurigena Antunes de Araújo; Caroline Addison Xavier Medeiros; Katarina Melo Chaves; Maria do Socorro Costa Feitosa Alves; Antonio Gouveia Oliveira; Rand Randall Martins
Journal:  Eur J Clin Pharmacol       Date:  2016-11-26       Impact factor: 2.953

7.  Drug-induced movement disorder and confusion associated with duloxetine.

Authors:  Sarah Hasan Siddiqui; Nadeem Ahmed Memon; Ravi Shanker
Journal:  BMJ Case Rep       Date:  2018-03-28

Review 8.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 9.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

Review 10.  Valproate-Associated Parkinsonism: A Critical Review of the Literature.

Authors:  Florian Brugger; Kailash P Bhatia; Frank M C Besag
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.